Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation Capacity
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.11.2026 · 198 (11) · 1437-1443
DOI: 10.1055/a-2786-2622 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.11.2026. Verfasst von Anne Bettina Beeskow und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Leipzig, Department of Diagnostic and Interventional Radiology, Germany, Leipzig. Hauptthemen laut MEDLINE: Catheter Ablation, Ketamine, Midazolam, Procedural Sedation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Percutaneous thermal tumor ablation is an established oncologic treatment, but rising case numbers and limited anesthesia resources increasingly restrict procedural capacity. Radiologist-guided analgosedation may offer a pragmatic alternative to general anesthesia for selected ablation procedures. This study evaluates the safety, technical success, and impact on procedural throughput of performing microwave (MWA) and radiofrequency ablation (RFA) of hepatic, renal, and osseous tumors under analgosedation with midazolam and S-ketamine. In this retrospective single-center study, 140 percutaneous tumor ablations performed in 115 patients under radiologist-guided analgosedation between January 2022 and July 2024 were analyzed. The primary endpoint was the occurrence of sedation-related complications. Secondary endpoints included technical success, ablation-related complications, and changes in procedural volume compared with ablations performed under general anesthesia. Technical success was defined as complete tumor ablation with an adequate safety margin. Of 115 planned patients, 113 (98.3%) were completed as intended. No major complications occurred. One minor complication (subcapsular hepatic hematoma, CIRSE grade 1) was observed. Four patients (3.5%) experienced transient post-interventional vomiting. No respiratory, cardiovascular, or anaphylactic adverse events were recorded. Transitioning from general anesthesia to analgosedation resulted in a significant increase in procedural volume from 2.1 to 6.3 ablations per month (p < 0.05). Mean in-room time was significantly shorter under analgosedation compared with general anesthesia (42 ± 34 min vs. 98 ± 42 min; p < 0.05). Radiologist-guided analgosedation with midazolam and S-ketamine is a feasible and safe approach for percutaneous thermal ablation of liver, kidney, and bone tumors. It enables high technical success without increasing complication rates and can substantially expand procedural capacity where anesthesiology resources are limited. Adequate training, structured workflows, and robust emergency preparedness are essential for safe implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University Hospital Leipzig, Department of Diagnostic and Interventional Radiology, Germany, Leipzig.
- University Hospital Leipzig, Department of Anesthesiology and Intensive care, SN, Germany, Leipzig.
- University Hospital Leipzig, Department of Internal Medicine II, Section Hepatology, SN, Germany, Leipzig.
- University Hospital Leipzig, Department of Visceral, Transplantation, Thoracic and Vascular Surgery, SN, Germany, Leipzig.
ORCID-Profile: Anne Bettina Beeskow, Manuel Florian Struck, Sebastian Ebel
Zitieren
APA
Beeskow, A. B., Struck, M. F., Elkilany, A., Meyer, H. J., Prasse, G., van Boemmel, F., Berg, T., Seehofer, D., Tautenhahn, H. M., Denecke, T., Gößmann, H., & Ebel, S. (2026). Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation Capacity. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 198(11), 1437-1443. https://doi.org/10.1055/a-2786-2622
Vancouver
Beeskow AB, Struck MF, Elkilany A, Meyer HJ, Prasse G, van Boemmel F, et al. Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation Capacity. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2026;198(11):1437-1443. doi:10.1055/a-2786-2622
BibTeX
@article{Beeskow2026,
author = {Beeskow, Anne Bettina and Struck, Manuel Florian and Elkilany, Aboelyazid and Meyer, Hans-Jonas and Prasse, Gordian and van Boemmel, Florian and Berg, Thomas and Seehofer, Daniel and Tautenhahn, Hans-Michael and Denecke, Timm and Gößmann, Holger and Ebel, Sebastian},
title = {Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation Capacity},
journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
year = {2026},
volume = {198},
number = {11},
pages = {1437--1443},
doi = {10.1055/a-2786-2622}
}
EUVIMED